Results 161 to 170 of about 63,641 (278)

Clarithromycin-induced rhabdomyolysis: a case report

open access: yesInternational Journal of General Medicine, 2012
Giuseppe Pasqualetti, Giacomo Bini, Sara Tognini, Antonio Polini, Fabio MonzaniGeriatrics Unit, Department of Internal Medicine, University Hospital of Pisa, Pisa, ItalyAbstract: Rhabdomyolysis is a clinical and laboratory syndrome that is caused by ...
Pasqualetti G   +4 more
doaj  

Primary aldosteronism with hypokalemic rhabdomyolysis: a case report and review of the literature

open access: yesJournal of Medical Case Reports
Background Hypokalemic rhabdomyolysis is a rare clinical manifestation of primary aldosteronism, making its diagnosis challenging, particularly when it becomes the primary presenting symptom.
Pingan Shi, Chao Wang, Yuanjun Lyu
doaj   +1 more source

Idiopathic rhabdomyolysis [PDF]

open access: yesArchives of Disease in Childhood, 1971
D C, Savage, M, Forbes, G W, Pearce
openaire   +2 more sources

Heart attack or rhabdomyolysis? [PDF]

open access: yes
Statins are commonly used drugs in the treatment of hyperlipidemia (HL), despite some undesirable side effects. These range from mild symptoms such as myopathy, muscle weakness and myalgia to severe muscle weakness associated with chronic myopathy and
Mustafa Bolatkale1 , Muhittin İşsever1 , Ulaş Karaoğlu1 , Ahmet,
core  

Recombinant antithrombin attenuates acute kidney injury associated with rhabdomyolysis: an in vivo animal study

open access: yesIntensive Care Medicine Experimental
Background Rhabdomyolysis is characterized by the destruction and necrosis of skeletal muscle tissue, resulting in acute kidney injury (AKI). Recombinant antithrombin (rAT) has DNA repair and vascular endothelial-protection properties.
Tomotaka Miura   +27 more
doaj   +1 more source

Pediatric rhabdomyolysis: a systematic review and meta-analysis of etiologies, management, and outcomes

open access: yesBMC Pediatrics
Background Rhabdomyolysis is a potentially fatal disorder that occurs due to various causes. Therefore, the aim of this meta-analysis was to identify the underlying causes, evaluate the treatment options, and determine the mortality and kidney outcomes ...
Hany A. Zaki   +5 more
doaj   +1 more source

Polysaccharide storage myopathy - the story so far [PDF]

open access: yes, 2015
Annandale   +45 more
core   +2 more sources

Levetiracetam and Rhabdomyolysis: A Rare but Clinically Significant Adverse Effect. [PDF]

open access: yesCureus
Ababio PA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy